- This Week's Most Viewed Threads
- 1
Post some TRADING PRINCIPLES that might help others (Not TA or systems)
Views: 2,609
PPC - 2
GBA PRESENTS- the public games <----- let's Go !!!!!!!!
GBA PRESENTS- the public games
- Thread starter stonedinvestor
- Start date
Pool Corp. price target raised by $72 at Baird, here's why » 06:49 POOL-
$327----------> $360 It's good to be back in the pool!!!!!!!!!!!!!!!!!
Holding time 1 day!!!!!!<-------
stonedinvestor said:
Stumbled across this dining stk. Wow! / I remember this being a $50 sort of name it has exploded. Is the food really good there or cheap? Has anyone gone to a Roadhouse?
TXRH Texas Roadhouse, Inc.
$150.683.04(+2.06%)4:00 PM 03/12/24
NASDAQ |$USD |Pre-Market:$152.30+1.62(+1.08%)8:32 AM
$167 now
#19945 Jul 5, 2024 Report
Reply Share
Texas Roadhouse price target raised by $19 at Loop Capital, here's why » 07:48 TXRH
Corrected to $166<-----!!
$172 at open<-----------
Stumbled across this dining stk. Wow! / I remember this being a $50 sort of name it has exploded. Is the food really good there or cheap? Has anyone gone to a Roadhouse?
TXRH Texas Roadhouse, Inc.
$150.683.04(+2.06%)4:00 PM 03/12/24
NASDAQ |$USD |Pre-Market:$152.30+1.62(+1.08%)8:32 AM
$167 now
#19945 Jul 5, 2024 Report
Reply Share
Texas Roadhouse price target raised by $19 at Loop Capital, here's why » 07:48 TXRH
Corrected to $166<-----!!
$172 at open<-----------
--Bread Financial price target raised by $6 at Compass Point, here's why » 07:31 BFH
--Nexstar announces $1.5B share repurchase authorization » 07:29 NXST
--Deckers Outdoor price target raised by $62 at Stifel, » 07:29 DECK
--Walmart to bet $200M on autonomous forklifts, Reuters says » 07:17 WMT
--Imax price target raised by $3 at Rosenblatt, » 07:11 IMAX
Up 8% yesterday it does this all the time... stay strong stoney stay strong!!!!
--Nexstar announces $1.5B share repurchase authorization » 07:29 NXST
--Deckers Outdoor price target raised by $62 at Stifel, » 07:29 DECK
--Walmart to bet $200M on autonomous forklifts, Reuters says » 07:17 WMT
--Imax price target raised by $3 at Rosenblatt, » 07:11 IMAX
Up 8% yesterday it does this all the time... stay strong stoney stay strong!!!!
Folks, my kid has the Covid I don't know if he's coming to Ct or staying here in the city. I want to get up and feed the birds and raccoons. Probably out of here by 10:00.
FTAI Aviation just upgraded at Stifel, » 07:09 FTAI
The strongest of the airplane-type stocks....
FTAI Aviation just upgraded at Stifel, » 07:09 FTAI
The strongest of the airplane-type stocks....
Strawberry Fields REIT initiated with bullish view at Alliance Global Partners, here's why » 07:04 STRW
4% yield./
STRW Strawberry Fields REIT, Inc.
$11.39 0.96(+9.20%)3:59 PM 07/25/24 <--- Up on a big down day!
4% yield./
STRW Strawberry Fields REIT, Inc.
$11.39 0.96(+9.20%)3:59 PM 07/25/24 <--- Up on a big down day!
Biodesix initiated with bullish view at Craig-Hallum » 07:22 BDSX
Mr. Cooper price target raised by $15 at Piper Sandler, » 06:53 COOP
Trade Desk should be bought on recent selloff, says Piper Sandler » 06:47 TTD
Duolingo upgraded to Buy at BofA following 31% pullback » 06:11 DUOL
BDSX Biodesix, Inc.- Cute little chart we should get $1.90 in this move. Then $2.70
$1.66 0.03(+1.84%)3:59 PM 07/25/24
NASDAQ |$USD |Post-Market:$1.68+0.02(+1.20%)4:00 PM
Company Profile
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient’s immune system to establish the patient’s prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
Mr. Cooper price target raised by $15 at Piper Sandler, » 06:53 COOP
Trade Desk should be bought on recent selloff, says Piper Sandler » 06:47 TTD
Duolingo upgraded to Buy at BofA following 31% pullback » 06:11 DUOL
BDSX Biodesix, Inc.- Cute little chart we should get $1.90 in this move. Then $2.70
$1.66 0.03(+1.84%)3:59 PM 07/25/24
NASDAQ |$USD |Post-Market:$1.68+0.02(+1.20%)4:00 PM
Company Profile
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient’s immune system to establish the patient’s prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
Biodesix affirms FY24 revenue view of $65M-$68M, consensus $66.2M 05/08 BDSX
Biodesix director buys $216.5K in common stock » 08/23/23 BDSX
stk was $1.60 or so back then.
Biodesix director buys $216.5K in common stock » 08/23/23 BDSX
stk was $1.60 or so back then.
If the week lasts through this weekend we are going to take the top spot!!!
In case it cuts off today----- let's make the public games #1
In case it cuts off today----- let's make the public games #1